NAPROXEN SODIUM TABLET, COATED

NAPROXEN SODIUM TABLET, COATED was reported 13692 times

NAPROXEN SODIUM TABLET, COATED is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 74 0.4966
1 C-REACTIVE PROTEIN 436 0.4703
2 GRIP STRENGTH 105 0.4585
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 903 0.4508
4 LUPUS VULGARIS 563 0.4468
5 SWOLLEN JOINT COUNT 110 0.4400
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 262 0.3922
7 FACET JOINT SYNDROME 1250 0.3836
8 SWOLLEN JOINT COUNT INCREASED 1140 0.3571
9 HYPOCHOLESTEROLAEMIA 115 0.3258
10 RHEUMATIC FEVER 1413 0.3167
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 650 0.3134
12 DISLOCATION OF VERTEBRA 705 0.3088
13 X-RAY ABNORMAL 475 0.2654
14 HUMAN ANTI-HUMAN ANTIBODY TEST 7 0.2593
15 DUODENAL ULCER PERFORATION 1804 0.2423
16 PERIPHERAL VENOUS DISEASE 989 0.2419
17 RHEUMATOID FACTOR POSITIVE 1366 0.2363
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1657 0.2310
19 BILE CAST NEPHROPATHY 7 0.2258
20 JOINT LAXITY 67 0.2219
21 RETINITIS 382 0.2209
22 SYNOVIAL FLUID ANALYSIS 19 0.2184
23 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 69 0.2054
24 SERONEGATIVE ARTHRITIS 232 0.2024
25 TENDER JOINT COUNT 17 0.2024
26 C-REACTIVE PROTEIN ABNORMAL 1299 0.2023
27 CONGENITAL HIATUS HERNIA 45 0.1974
28 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 20 0.1905
29 MUSCLE INJURY 1515 0.1827
30 PORPHYRIA ACUTE 251 0.1749
31 HELICOBACTER INFECTION 1790 0.1740
32 FOLLICULITIS 1791 0.1706
33 ACQUIRED PORPHYRIA 12 0.1690
34 BREAST CANCER STAGE III 1024 0.1580
35 PEMPHIGUS 1882 0.1504
36 HAND DEFORMITY 1954 0.1488
37 LIP DRY 1298 0.1428
38 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 312 0.1353
39 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 864 0.1329
40 SHORT STATURE 34 0.1298
41 OVERLAP SYNDROME 85 0.1214
42 LOOSE BODY IN JOINT 32 0.1203
43 SYNOVITIS 2148 0.1190
44 BONE EROSION 417 0.1178
45 JOINT RANGE OF MOTION DECREASED 1548 0.1153
46 BLEPHAROSPASM 657 0.1042
47 BODY HEIGHT BELOW NORMAL 67 0.1042
48 PERICARDITIS 1748 0.1039
49 WOUND INFECTION 1122 0.1024
50 BURSITIS 1239 0.1020
51 GRIP STRENGTH DECREASED 858 0.0974
52 HYPERCHOLESTEROLAEMIA 928 0.0960
53 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 52 0.0927
54 GLOSSODYNIA 2036 0.0908
55 JOINT DESTRUCTION 140 0.0900
56 AUTOIMMUNE DISORDER 872 0.0894
57 FIBROMYALGIA 2140 0.0879
58 DRUG TOLERANCE DECREASED 246 0.0875
59 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 69 0.0865
60 ONYCHOMADESIS 352 0.0838
61 IRRITABLE BOWEL SYNDROME 1742 0.0812
62 BONE DENSITY INCREASED 32 0.0802
63 LIVE BIRTH 658 0.0786
64 MALIGNANT MELANOMA STAGE 0 15 0.0718
65 OBESITY 1141 0.0715
66 LIVER INJURY 1709 0.0696
67 SCIATICA 1061 0.0665
68 WOUND 1858 0.0664
69 NAIL DISORDER 530 0.0605
70 OESOPHAGEAL SPASM 111 0.0602
71 IMPAIRED HEALING 1937 0.0589
72 ONYCHOMYCOSIS 257 0.0585
73 PRESCRIBED OVERDOSE 1059 0.0547
74 FINGER DEFORMITY 261 0.0538
75 SYSTEMIC LUPUS ERYTHEMATOSUS 1884 0.0530
76 TYPE 2 DIABETES MELLITUS 1748 0.0519
77 BUNION OPERATION 29 0.0517
78 EXOSTOSIS 466 0.0510
79 CONTRAINDICATED PRODUCT ADMINISTERED 1510 0.0498
80 LOWER LIMB FRACTURE 913 0.0475
81 ULCER HAEMORRHAGE 318 0.0469
82 ANKLE ARTHROPLASTY 17 0.0468
83 PSORIATIC ARTHROPATHY 1896 0.0467
84 ANTIPHOSPHOLIPID ANTIBODIES 9 0.0462
85 TENOSYNOVITIS STENOSANS 25 0.0449
86 LUPUS-LIKE SYNDROME 406 0.0447
87 WALKING AID USER 294 0.0445
88 MATERNAL EXPOSURE TIMING UNSPECIFIED 163 0.0434
89 RED BLOOD CELL SEDIMENTATION RATE INCREASED 473 0.0427
90 PULMONARY FIBROSIS 819 0.0427
91 EYE INJURY 128 0.0421
92 ANTIBODY TEST POSITIVE 69 0.0415
93 PRODUCT LABEL CONFUSION 236 0.0405
94 SYNOVIAL DISORDER 18 0.0396
95 FOOT DEFORMITY 430 0.0388
96 DRUG SPECIFIC ANTIBODY 53 0.0387
97 DRUG TOLERANCE 193 0.0381
98 RHEUMATOID NODULE 104 0.0377
99 NIGHT SWEATS 1194 0.0370
100 BLOOD CHOLESTEROL INCREASED 1702 0.0365
101 BACK INJURY 396 0.0364
102 ARTHROPATHY 2017 0.0363
103 SPONDYLITIS 131 0.0360
104 POLYARTHRITIS 189 0.0358
105 FRACTURE DELAYED UNION 30 0.0355
106 PRESCRIBED UNDERDOSE 708 0.0355
107 INFUSION SITE REACTION 106 0.0355
108 HIP ARTHROPLASTY 540 0.0352
109 GAIT INABILITY 1145 0.0342
110 LOWER RESPIRATORY TRACT INFECTION 1501 0.0330
111 OSTEOARTHRITIS 1378 0.0325
112 JUVENILE IDIOPATHIC ARTHRITIS 74 0.0302
113 WHEEZING 1786 0.0301
114 JOINT DISLOCATION 318 0.0301
115 BREAST CANCER STAGE II 249 0.0299
116 BLISTER 1659 0.0295
117 TASTE DISORDER 596 0.0293
118 CONGENITAL ANOMALY 227 0.0293
119 OESOPHAGEAL PAIN 114 0.0288
120 C-REACTIVE PROTEIN INCREASED 1029 0.0283
121 INFUSION RELATED REACTION 1863 0.0281
122 STOMATITIS 1674 0.0276
123 THERAPEUTIC PRODUCT EFFECT DECREASED 1220 0.0272
124 RED BLOOD CELL SEDIMENTATION RATE DECREASED 7 0.0268
125 HEPATIC ENZYME INCREASED 1829 0.0268
126 PSEUDOPORPHYRIA 9 0.0263
127 INFLAMMATION 1354 0.0262
128 MOBILITY DECREASED 1842 0.0256
129 LUNG DISORDER 1251 0.0255
130 OEDEMA 1380 0.0254
131 INJURY 1753 0.0249
132 ALLERGY TO CHEMICALS 31 0.0249
133 MUSCULOSKELETAL PAIN 1277 0.0244
134 COELIAC DISEASE 239 0.0243
135 ROAD TRAFFIC ACCIDENT 1010 0.0241
136 RHEUMATOID LUNG 23 0.0241
137 SPINAL FUSION SURGERY 97 0.0239
138 LIVER FUNCTION TEST INCREASED 507 0.0236
139 DISCOMFORT 1419 0.0232
140 LYMPHOEDEMA 160 0.0231
141 KNEE ARTHROPLASTY 487 0.0231
142 LIVER DISORDER 948 0.0214
143 EPILEPSY 642 0.0210
144 HEPATIC CIRRHOSIS 382 0.0203
145 DELIRIUM 698 0.0201
146 DRUG INTOLERANCE 1941 0.0201
147 SWELLING 1876 0.0200
148 LIMB DEFORMITY 31 0.0195
149 ILL-DEFINED DISORDER 1168 0.0192
150 ADVERSE REACTION 254 0.0191
151 OCCULT BLOOD 10 0.0190
152 THERAPY NON-RESPONDER 855 0.0190
153 GENERALISED BULLOUS FIXED DRUG ERUPTION 7 0.0188
154 RHEUMATOID ARTHRITIS 2133 0.0188
155 OBSTRUCTIVE SLEEP APNOEA SYNDROME 27 0.0185
156 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 316 0.0184
157 MUSCULOSKELETAL STIFFNESS 1609 0.0183
158 DRY MOUTH 1484 0.0183
159 JOINT SWELLING 2189 0.0181
160 NORMAL NEWBORN 98 0.0180
161 DRUG-INDUCED LIVER INJURY 559 0.0178
162 MATERNAL EXPOSURE DURING PREGNANCY 1566 0.0176
163 EXPOSURE TO TOXIC AGENT 56 0.0175
164 EPIDERMAL NECROSIS 17 0.0175
165 PERFORATION 14 0.0174
166 DISABILITY 336 0.0170
167 MALIGNANT MELANOMA IN SITU 21 0.0169
168 OSTEOPOROTIC FRACTURE 32 0.0167
169 SLEEP DISORDER 1177 0.0167
170 PUSTULAR PSORIASIS 56 0.0163
171 OSTEOPOROSIS 659 0.0160
172 GENERAL PHYSICAL HEALTH DETERIORATION 1833 0.0158
173 PREGNANCY 316 0.0158
174 PLEURAL FIBROSIS 16 0.0157
175 ADRENAL INSUFFICIENCY 190 0.0156
176 JOINT STIFFNESS 410 0.0156
177 HEPATIC ENZYME DECREASED 7 0.0156
178 INTENTIONAL PRODUCT USE ISSUE 1357 0.0155
179 AMBLYOPIA 9 0.0152
180 TREATMENT FAILURE 1238 0.0149
181 SCLERITIS 23 0.0143
182 WHEELCHAIR USER 63 0.0142
183 MIGRAINE 1328 0.0139
184 GRANULOMA SKIN 11 0.0134
185 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 224 0.0132
186 GASTROINTESTINAL DISORDER 1181 0.0132
187 EAR INFECTION 344 0.0129
188 DEAFNESS TRANSITORY 11 0.0129
189 HYPOAESTHESIA 1888 0.0126
190 EAR PAIN 243 0.0125
191 ABDOMINAL DISCOMFORT 2073 0.0123
192 SINUSITIS 1261 0.0123
193 EXPOSURE DURING PREGNANCY 748 0.0120
194 PRECANCEROUS CONDITION 8 0.0119
195 WEIGHT FLUCTUATION 121 0.0116
196 ALLERGY TO METALS 7 0.0115
197 DEATH NEONATAL 16 0.0115
198 PERIPHERAL SWELLING 1763 0.0114
199 URTICARIA 1912 0.0114
200 DYSPEPSIA 1099 0.0112
201 GASTROOESOPHAGEAL REFLUX DISEASE 867 0.0108
202 INFECTION 1553 0.0107
203 FREQUENT BOWEL MOVEMENTS 288 0.0107
204 CONTUSION 1021 0.0106
205 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 509 0.0106
206 APPENDIX DISORDER 15 0.0106
207 RASH VESICULAR 51 0.0105
208 IMMUNODEFICIENCY 157 0.0105
209 AMNESIA 684 0.0105
210 CONFUSIONAL STATE 1674 0.0103
211 BREATH SOUNDS ABNORMAL 51 0.0103
212 HEPATITIS 263 0.0103
213 TENOSYNOVITIS 28 0.0101
214 PEPTIC ULCER HAEMORRHAGE 7 0.0100
215 HYPERSENSITIVITY 1864 0.0100
216 GINGIVAL INFECTION 8 0.0100
217 PLEURITIC PAIN 27 0.0098
218 FOOT OPERATION 48 0.0097
219 BENIGN PROSTATIC HYPERPLASIA 50 0.0097
220 ALOPECIA 1860 0.0095
221 ABDOMINAL PAIN UPPER 1878 0.0091
222 MEMORY IMPAIRMENT 1251 0.0091
223 SUSPECTED OFF LABEL USE 41 0.0091
224 RESPIRATORY DISORDER 271 0.0090
225 JOINT EFFUSION 62 0.0090
226 MULTIPLE FRACTURES 144 0.0088
227 HYPERTENSION 1854 0.0087
228 BLOOD PRESSURE DIASTOLIC ABNORMAL 22 0.0086
229 NASOPHARYNGITIS 1576 0.0085
230 ASTHMA 960 0.0085
231 CREPITATIONS 25 0.0084
232 MUSCULAR WEAKNESS 923 0.0081
233 BLOOD PRESSURE SYSTOLIC ABNORMAL 20 0.0081
234 SLEEP APNOEA SYNDROME 154 0.0081
235 HYPERTRANSAMINASAEMIA 56 0.0080
236 WEIGHT INCREASED 1794 0.0080
237 FEMUR FRACTURE 241 0.0078
238 NECK PAIN 430 0.0077
239 PARAESTHESIA 1201 0.0076
240 CUSHINGOID 24 0.0075
241 GENERAL SYMPTOM 56 0.0075
242 BLOOD PARATHYROID HORMONE DECREASED 11 0.0074
243 MEDICATION ERROR 410 0.0074
244 NERVE INJURY 82 0.0074
245 DUODENAL ULCER 52 0.0074
246 CONDITION AGGRAVATED 2192 0.0072
247 ADVERSE EVENT 664 0.0072
248 CROSS SENSITIVITY REACTION 7 0.0072
249 LYMPHOCYTE COUNT ABNORMAL 8 0.0071
250 GASTRIC ULCER PERFORATION 9 0.0071
251 FIXED ERUPTION 12 0.0070
252 CYSTITIS 218 0.0068
253 BRONCHIECTASIS 46 0.0068
254 ANTINUCLEAR ANTIBODY POSITIVE 22 0.0068
255 RECTAL HAEMORRHAGE 286 0.0067
256 MUSCLE SPASMS 1215 0.0066
257 KERATITIS 20 0.0066
258 MYOSITIS 59 0.0066
259 ASPARTATE AMINOTRANSFERASE ABNORMAL 10 0.0066
260 NODULE 85 0.0065
261 ARTHRITIS 509 0.0065
262 PULMONARY CONGESTION 84 0.0064
263 FUNCTIONAL GASTROINTESTINAL DISORDER 22 0.0064
264 UNDERDOSE 464 0.0064
265 UPPER RESPIRATORY TRACT INFECTION 293 0.0063
266 DIVERTICULAR PERFORATION 13 0.0063
267 ANAL ABSCESS 34 0.0063
268 ARTERIOSCLEROSIS CORONARY ARTERY 41 0.0062
269 COLITIS ULCERATIVE 276 0.0062
270 BILIARY OBSTRUCTION 8 0.0062
271 GASTROENTERITIS VIRAL 111 0.0061
272 NECK INJURY 18 0.0061
273 DECREASED APPETITE 1417 0.0061
274 TOOTH INFECTION 80 0.0061
275 PHARYNGITIS 75 0.0060
276 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 16 0.0060
277 DEPRESSION 1365 0.0060
278 OEDEMA PERIPHERAL 730 0.0060
279 CHEST PAIN 1094 0.0059
280 LOWER RESPIRATORY TRACT CONGESTION 10 0.0059
281 HAEMATOCRIT DECREASED 116 0.0058
282 MAST CELL ACTIVATION SYNDROME 8 0.0057
283 SPUTUM DISCOLOURED 54 0.0057
284 PRODUCT USE ISSUE 1063 0.0057
285 NECK MASS 16 0.0056
286 PALATAL OEDEMA 7 0.0056
287 SMEAR CERVIX ABNORMAL 8 0.0056
288 JOINT INJURY 120 0.0056
289 ARTHRALGIA 2321 0.0056
290 ADVERSE DRUG REACTION 497 0.0055
291 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 392 0.0055
292 RENAL TUBULAR ACIDOSIS 12 0.0055
293 HYPOCALCAEMIA 104 0.0055
294 RASH 2384 0.0055
295 LABORATORY TEST ABNORMAL 161 0.0055
296 SYNOVIAL CYST 25 0.0054
297 INCORRECT PRODUCT ADMINISTRATION DURATION 115 0.0053
298 WHITE BLOOD CELL COUNT INCREASED 202 0.0053
299 FEELING HOT 318 0.0052
300 BACK DISORDER 83 0.0051
301 QUALITY OF LIFE DECREASED 68 0.0051
302 JOINT ARTHROPLASTY 9 0.0050
303 FLUID RETENTION 252 0.0049
304 VOMITING 2263 0.0048
305 PAIN IN EXTREMITY 1416 0.0048
306 HYPERPARATHYROIDISM SECONDARY 12 0.0048
307 BONE DISORDER 87 0.0048
308 ABDOMINAL PAIN 1110 0.0048
309 INSOMNIA 1263 0.0047
310 RESPIRATORY TRACT CONGESTION 75 0.0047
311 THERAPEUTIC RESPONSE DECREASED 284 0.0047
312 INJECTION SITE REACTION 320 0.0046
313 BRONCHITIS 342 0.0046
314 PRODUCT USE IN UNAPPROVED INDICATION 1143 0.0046
315 PANNICULITIS 11 0.0045
316 GAIT DISTURBANCE 868 0.0045
317 PANCREATITIS 237 0.0045
318 ENTHESOPATHY 7 0.0045
319 VARICOSE VEIN 23 0.0044
320 FULL BLOOD COUNT ABNORMAL 47 0.0044
321 PYREXIA 1535 0.0044
322 STRIDOR 13 0.0044
323 HUNGER 61 0.0044
324 THROMBOCYTOSIS 16 0.0044
325 PRODUCT QUALITY ISSUE 592 0.0044
326 PRE-EXISTING CONDITION IMPROVED 27 0.0043
327 RED BLOOD CELL COUNT DECREASED 123 0.0043
328 SACROILIITIS 8 0.0042
329 MUSCLE SPASTICITY 52 0.0042
330 PAIN 2596 0.0042
331 TENDERNESS 44 0.0042
332 BILE DUCT OBSTRUCTION 8 0.0042
333 DIZZINESS 2097 0.0042
334 PERIODONTITIS 9 0.0042
335 PNEUMONIA 1334 0.0041
336 TOOTH DISORDER 90 0.0040
337 CHOLESTATIC LIVER INJURY 9 0.0040
338 MALAISE 1766 0.0040
339 GASTRIC ULCER HAEMORRHAGE 22 0.0040
340 ULCER 63 0.0040
341 ANXIETY 1127 0.0040
342 PULMONARY TOXICITY 28 0.0040
343 ASTHENIA 1485 0.0039
344 HYPOKALAEMIA 182 0.0039
345 TOOTHACHE 71 0.0039
346 OSTEOLYSIS 8 0.0039
347 GASTRIC ULCER 74 0.0039
348 DUODENAL ULCER HAEMORRHAGE 11 0.0038
349 VISUAL IMPAIRMENT 476 0.0038
350 INFLAMMATORY MARKER INCREASED 19 0.0038
351 MEAN CELL HAEMOGLOBIN DECREASED 7 0.0038
352 BODY TEMPERATURE ABNORMAL 7 0.0038
353 EXPIRED PRODUCT ADMINISTERED 125 0.0038
354 PROTEIN TOTAL INCREASED 10 0.0038
355 GASTROINTESTINAL TOXICITY 18 0.0037
356 HEPATIC NECROSIS 14 0.0037
357 PRURITUS 1406 0.0037
358 SEPTIC SHOCK 159 0.0037
359 KIDNEY INFECTION 71 0.0036
360 VAGINAL INFECTION 17 0.0036
361 DIARRHOEA 2319 0.0036
362 VENTRICULAR HYPERTROPHY 9 0.0036
363 URINARY TRACT INFECTION BACTERIAL 9 0.0036
364 KOUNIS SYNDROME 8 0.0035
365 FLANK PAIN 33 0.0035
366 FATIGUE 2740 0.0035
367 FOREIGN BODY 14 0.0035
368 ANKYLOSING SPONDYLITIS 46 0.0035
369 WEIGHT DECREASED 973 0.0035
370 BONE DENSITY ABNORMAL 13 0.0035
371 HYPERSENSITIVITY VASCULITIS 9 0.0034
372 OBSTRUCTIVE AIRWAYS DISORDER 38 0.0034
373 RASH PRURITIC 184 0.0034
374 NASAL DISORDER 9 0.0034
375 INSULIN RESISTANCE 7 0.0034
376 LARYNGOSPASM 9 0.0033
377 IRON DEFICIENCY 15 0.0033
378 PSORIASIS 435 0.0033
379 MICTURITION URGENCY 38 0.0033
380 ACNE CYSTIC 10 0.0033
381 LIMB DISCOMFORT 102 0.0033
382 PROSTATE CANCER METASTATIC 11 0.0033
383 ORAL FUNGAL INFECTION 9 0.0033
384 BONE DENSITY DECREASED 103 0.0033
385 NEPHROGENIC ANAEMIA 15 0.0032
386 EXPOSED BONE IN JAW 7 0.0032
387 ABDOMINAL DISTENSION 335 0.0032
388 TOXIC EPIDERMAL NECROLYSIS 48 0.0032
389 HEADACHE 1976 0.0031
390 UPPER RESPIRATORY TRACT CONGESTION 9 0.0031
391 ATELECTASIS 30 0.0031
392 SPINAL OSTEOARTHRITIS 27 0.0031
393 TINNITUS 140 0.0030
394 TACHYCARDIA 269 0.0030
395 OFF LABEL USE 2616 0.0030
396 REBOUND ACID HYPERSECRETION 9 0.0030
397 TENDONITIS 45 0.0029
398 CHOLECYSTITIS CHRONIC 19 0.0028
399 DRUG ERUPTION 50 0.0028
400 POISONING 35 0.0028
401 DEFORMITY 26 0.0028
402 DYSPNOEA 1573 0.0028
403 ENDOMETRIOSIS 13 0.0027
404 NERVE COMPRESSION 25 0.0027
405 BREAST CANCER STAGE I 25 0.0027
406 URINARY TRACT DISORDER 12 0.0027
407 FOETAL EXPOSURE DURING PREGNANCY 215 0.0026
408 HALLUCINATION 197 0.0026
409 AGITATION 190 0.0026
410 URINE ODOUR ABNORMAL 15 0.0025
411 NAUSEA 2002 0.0025
412 NON-CARDIAC CHEST PAIN 8 0.0025
413 NEPHROLITHIASIS 114 0.0025
414 PNEUMONIA ASPIRATION 62 0.0025
415 ASPIRATION 27 0.0025
416 BODY TEMPERATURE INCREASED 50 0.0024
417 TONGUE DISCOMFORT 10 0.0024
418 PERIORBITAL OEDEMA 12 0.0023
419 IRITIS 7 0.0023
420 VULVOVAGINAL PAIN 11 0.0023
421 FRACTURE 43 0.0023
422 BLOOD ALBUMIN DECREASED 18 0.0023
423 TOOTH ABSCESS 23 0.0023
424 DRUG INEFFECTIVE 2973 0.0023
425 NO ADVERSE EVENT 407 0.0022
426 PRODUCTIVE COUGH 107 0.0022
427 ABNORMAL LOSS OF WEIGHT 15 0.0022
428 IMPAIRED WORK ABILITY 47 0.0022
429 CONJUNCTIVITIS 40 0.0022
430 DRUG SCREEN POSITIVE 17 0.0021
431 DECREASED IMMUNE RESPONSIVENESS 21 0.0021
432 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0021
433 SKIN NECROSIS 11 0.0021
434 DIVERTICULUM 15 0.0021
435 OLIGOHYDRAMNIOS 7 0.0021
436 NON-SMALL CELL LUNG CANCER 10 0.0021
437 THERAPEUTIC PRODUCT INEFFECTIVE 8 0.0021
438 EUPHORIC MOOD 21 0.0020
439 TORSADE DE POINTES 16 0.0020
440 GINGIVITIS 11 0.0020
441 PLEURAL EFFUSION 124 0.0020
442 MUSCULOSKELETAL DISCOMFORT 35 0.0020
443 ERYTHEMA NODOSUM 7 0.0020
444 STEVENS-JOHNSON SYNDROME 44 0.0020
445 HAEMOGLOBIN INCREASED 9 0.0020
446 FALL 656 0.0020
447 BLOOD CHOLESTEROL ABNORMAL 9 0.0019
448 SELF-MEDICATION 8 0.0019
449 TENDON RUPTURE 24 0.0019
450 FOOD ALLERGY 15 0.0019
451 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
452 HAEMOGLOBIN DECREASED 197 0.0019
453 PHOTOPHOBIA 36 0.0019
454 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
455 LIP OEDEMA 8 0.0019
456 PARAESTHESIA ORAL 27 0.0019
457 TUBULOINTERSTITIAL NEPHRITIS 35 0.0019
458 TRANSIENT ISCHAEMIC ATTACK 63 0.0019
459 MELAENA 41 0.0019
460 SNORING 7 0.0018
461 TREATMENT NONCOMPLIANCE 101 0.0018
462 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
463 LEUKOPENIA 92 0.0018
464 TONGUE OEDEMA 7 0.0018
465 SPINAL DISORDER 17 0.0018
466 HEART RATE ABNORMAL 10 0.0018
467 POST-TRAUMATIC STRESS DISORDER 12 0.0018
468 LOSS OF CONSCIOUSNESS 229 0.0018
469 FEELING JITTERY 34 0.0018
470 PAPILLOEDEMA 8 0.0018
471 SEASONAL ALLERGY 25 0.0018
472 ANGIOEDEMA 78 0.0018
473 ACCIDENT 21 0.0018
474 MATERNAL EXPOSURE BEFORE PREGNANCY 12 0.0018
475 HYPERHIDROSIS 226 0.0018
476 HYSTERECTOMY 15 0.0017
477 BASAL CELL CARCINOMA 27 0.0017
478 GASTROINTESTINAL PAIN 19 0.0017
479 BODY TEMPERATURE DECREASED 17 0.0017
480 URINE OUTPUT DECREASED 15 0.0017
481 SENSITIVITY TO WEATHER CHANGE 9 0.0017
482 SKIN ULCER 44 0.0017
483 HOSPITALISATION 255 0.0017
484 DYSMENORRHOEA 22 0.0017
485 TONGUE DISORDER 12 0.0017
486 LIVER FUNCTION TEST ABNORMAL 48 0.0016
487 BLOOD TRIGLYCERIDES INCREASED 29 0.0016
488 TENSION HEADACHE 7 0.0016
489 BLOOD PRESSURE FLUCTUATION 39 0.0016
490 CORONARY ARTERY DISEASE 49 0.0016
491 SCOLIOSIS 10 0.0016
492 END STAGE RENAL DISEASE 29 0.0016
493 COMA 75 0.0016
494 HEPATOTOXICITY 35 0.0016
495 VENTRICULAR SEPTAL DEFECT 9 0.0016
496 FEELING ABNORMAL 371 0.0015
497 APHTHOUS ULCER 12 0.0015
498 INTENTIONAL OVERDOSE 99 0.0015
499 HEPATITIS ACUTE 10 0.0015
500 HAEMATEMESIS 39 0.0015
501 RASH ERYTHEMATOUS 73 0.0015
502 NEURALGIA 37 0.0015
503 SINUS HEADACHE 9 0.0015
504 GASTRITIS EROSIVE 7 0.0015
505 BACTERIAL INFECTION 28 0.0015
506 CARPAL TUNNEL SYNDROME 21 0.0015
507 SUICIDE ATTEMPT 90 0.0015
508 ANAPHYLACTIC REACTION 82 0.0015
509 NEUTROPHIL COUNT INCREASED 15 0.0015
510 THROMBOCYTOPENIA 159 0.0014
511 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 11 0.0014
512 INADEQUATE ANALGESIA 12 0.0014
513 DYSPNOEA EXERTIONAL 53 0.0014
514 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
515 VITAMIN D DECREASED 12 0.0014
516 SCAB 16 0.0014
517 FEAR OF INJECTION 10 0.0014
518 CHOLECYSTECTOMY 16 0.0014
519 INTERSTITIAL LUNG DISEASE 67 0.0014
520 FAECES DISCOLOURED 30 0.0014
521 PLATELET COUNT INCREASED 18 0.0014
522 HYPERCALCAEMIA 17 0.0014
523 INCORRECT DRUG ADMINISTRATION DURATION 38 0.0013
524 RASH MACULO-PAPULAR 30 0.0013
525 MALABSORPTION 7 0.0013
526 HEPATITIS CHOLESTATIC 8 0.0013
527 SERUM FERRITIN INCREASED 7 0.0013
528 VISION BLURRED 181 0.0013
529 MUSCULOSKELETAL DISORDER 25 0.0013
530 CENTRAL NERVOUS SYSTEM LESION 18 0.0013
531 COLD SWEAT 23 0.0013
532 CARDIOMEGALY 16 0.0013
533 LARYNGEAL OEDEMA 8 0.0013
534 ORAL DISCOMFORT 18 0.0013
535 BLOOD PRESSURE INCREASED 196 0.0013
536 PULMONARY MASS 19 0.0013
537 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
538 DERMATITIS ALLERGIC 16 0.0013
539 GINGIVAL PAIN 10 0.0013
540 UVEITIS 17 0.0013
541 RASH PAPULAR 28 0.0012
542 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
543 POOR QUALITY PRODUCT ADMINISTERED 13 0.0012
544 PHARYNGEAL SWELLING 12 0.0012
545 INFLAMMATORY BOWEL DISEASE 12 0.0012
546 RENAL PAIN 13 0.0012
547 MUCOSAL INFLAMMATION 32 0.0012
548 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
549 VISUAL DISTURBANCE 7 0.0012
550 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
551 SOMNAMBULISM 8 0.0012
552 SPINAL OPERATION 15 0.0012
553 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
554 OPTIC NEURITIS 11 0.0012
555 LIP SWELLING 40 0.0012
556 OVERDOSE 259 0.0012
557 INTENTIONAL PRODUCT MISUSE 105 0.0012
558 SKIN DISORDER 40 0.0012
559 DERMATITIS 25 0.0012
560 IRON DEFICIENCY ANAEMIA 11 0.0012
561 HYPOTENSION 239 0.0012
562 TENDON PAIN 9 0.0012
563 SKIN PLAQUE 10 0.0012
564 HYPERLIPIDAEMIA 14 0.0012
565 PROTHROMBIN TIME PROLONGED 7 0.0012
566 CONCUSSION 9 0.0012
567 DIABETES MELLITUS 88 0.0012
568 PETECHIAE 12 0.0011
569 TENSION 7 0.0011
570 BACK PAIN 263 0.0011
571 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 59 0.0011
572 RESPIRATORY RATE INCREASED 10 0.0011
573 EYE DISORDER 37 0.0011
574 RENAL TUBULAR NECROSIS 11 0.0011
575 EYELID OEDEMA 13 0.0011
576 SWELLING OF EYELID 7 0.0011
577 SPINAL PAIN 13 0.0011
578 CHRONIC KIDNEY DISEASE 84 0.0011
579 OESOPHAGITIS 12 0.0011
580 ACCIDENTAL OVERDOSE 40 0.0011
581 SWELLING FACE 71 0.0011
582 INCOHERENT 7 0.0011
583 THROAT IRRITATION 48 0.0011
584 SOMNOLENCE 215 0.0011
585 TEMPERATURE INTOLERANCE 11 0.0011
586 HYPERBILIRUBINAEMIA 11 0.0011
587 BLOOD SODIUM DECREASED 20 0.0011
588 SURGERY 62 0.0011
589 SINUS TACHYCARDIA 15 0.0011
590 HYPERKALAEMIA 37 0.0011
591 GASTRIC DISORDER 36 0.0010
592 MOUTH ULCERATION 22 0.0010
593 RENAL INJURY 31 0.0010
594 PROCEDURAL COMPLICATION 8 0.0010
595 BREAST MASS 7 0.0010
596 CHOLELITHIASIS 34 0.0010
597 WRONG PRODUCT ADMINISTERED 7 0.0010
598 DEAFNESS 27 0.0010
599 MYOCARDIAL INFARCTION 180 0.0010
600 VENTRICULAR TACHYCARDIA 17 0.0010
601 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
602 ATRIAL FIBRILLATION 99 0.0010
603 ROTATOR CUFF SYNDROME 13 0.0010
604 TOXICITY TO VARIOUS AGENTS 170 0.0010
605 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
606 DRY EYE 50 0.0010
607 OXYGEN SATURATION DECREASED 56 0.0010
608 NOCTURIA 12 0.0010
609 ORAL CANDIDIASIS 13 0.0010
610 SHOCK HAEMORRHAGIC 8 0.0010
611 INJECTION SITE URTICARIA 24 0.0010
612 PHARYNGEAL OEDEMA 15 0.0010
613 IMPAIRED QUALITY OF LIFE 14 0.0010
614 NASAL CONGESTION 57 0.0010
615 MAJOR DEPRESSION 7 0.0010
616 ACUTE KIDNEY INJURY 146 0.0010
617 GALLBLADDER DISORDER 17 0.0010
618 GASTRITIS 25 0.0009
619 TRANSAMINASES INCREASED 21 0.0009
620 FEELING DRUNK 7 0.0009
621 HYPOTHYROIDISM 30 0.0009
622 BLOOD IRON DECREASED 11 0.0009
623 DISSEMINATED INTRAVASCULAR COAGULATION 13 0.0009
624 BIPOLAR DISORDER 10 0.0009
625 RENAL FAILURE ACUTE 39 0.0009
626 BLOOD CREATININE INCREASED 60 0.0009
627 SEDATION 24 0.0009
628 METABOLIC ACIDOSIS 29 0.0009
629 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
630 DYSSTASIA 26 0.0009
631 SINUS CONGESTION 12 0.0009
632 MYALGIA 151 0.0009
633 EYE PAIN 50 0.0009
634 CHROMATURIA 20 0.0009
635 COUGH 248 0.0009
636 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 6 0.0009
637 TRICUSPID VALVE INCOMPETENCE 7 0.0009
638 EAR DISCOMFORT 9 0.0009
639 CELLULITIS 44 0.0009
640 INTERVERTEBRAL DISC PROTRUSION 19 0.0009
641 DIVERTICULITIS 24 0.0009
642 INJECTION SITE IRRITATION 11 0.0009
643 OROPHARYNGEAL PAIN 80 0.0009
644 CARDIO-RESPIRATORY ARREST 36 0.0009
645 ERYTHEMA MULTIFORME 8 0.0009
646 JAUNDICE 23 0.0009
647 THROAT TIGHTNESS 23 0.0008
648 HIATUS HERNIA 11 0.0008
649 HAEMATURIA 29 0.0008
650 DEEP VEIN THROMBOSIS 55 0.0008
651 EATING DISORDER 18 0.0008
652 RESPIRATORY TRACT INFECTION 22 0.0008
653 FUNGAL INFECTION 28 0.0008
654 THIRST 15 0.0008
655 FEEDING DISORDER 17 0.0008
656 INFUSION SITE ERYTHEMA 7 0.0008
657 SOPOR 11 0.0008
658 DRUG ABUSE 69 0.0008
659 SKIN LACERATION 9 0.0008
660 MENTAL IMPAIRMENT 20 0.0008
661 RESTLESS LEGS SYNDROME 15 0.0008
662 VITAMIN D DEFICIENCY 8 0.0008
663 PRODUCT TASTE ABNORMAL 11 0.0008
664 PSYCHOLOGICAL TRAUMA 7 0.0008
665 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
666 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
667 ACUTE HEPATIC FAILURE 11 0.0008
668 SKIN INFECTION 9 0.0008
669 SKIN LESION 22 0.0008
670 BLOOD CALCIUM DECREASED 9 0.0008
671 RESPIRATORY ARREST 22 0.0008
672 HEART RATE DECREASED 28 0.0008
673 GROIN PAIN 7 0.0008
674 MITRAL VALVE INCOMPETENCE 9 0.0008
675 FOOT FRACTURE 15 0.0008
676 OSTEOPENIA 12 0.0008
677 ACIDOSIS 6 0.0008
678 FACIAL PAIN 7 0.0008
679 DISORIENTATION 31 0.0008
680 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 140 0.0008
681 PAIN IN JAW 22 0.0008
682 VASCULITIS 9 0.0008
683 PERITONITIS 16 0.0008
684 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
685 VENTRICULAR EXTRASYSTOLES 8 0.0008
686 CHOKING 15 0.0008
687 SWOLLEN TONGUE 24 0.0008
688 COMPLETED SUICIDE 64 0.0008
689 LYMPHADENOPATHY 27 0.0008
690 SINUS DISORDER 15 0.0008
691 INCONTINENCE 8 0.0008
692 PNEUMOTHORAX 12 0.0008
693 PANCREATITIS ACUTE 17 0.0008
694 BLOOD PRESSURE ABNORMAL 15 0.0008
695 BODY HEIGHT DECREASED 8 0.0007
696 RENAL FAILURE 99 0.0007
697 HOT FLUSH 56 0.0007
698 PRURITUS GENERALISED 16 0.0007
699 ERYTHEMA 152 0.0007
700 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
701 IMPAIRED GASTRIC EMPTYING 10 0.0007
702 ABNORMAL FAECES 6 0.0007
703 PERIPHERAL COLDNESS 10 0.0007
704 GENERALISED OEDEMA 9 0.0007
705 SINUS BRADYCARDIA 7 0.0007
706 ANHEDONIA 19 0.0007
707 COAGULOPATHY 12 0.0007
708 COORDINATION ABNORMAL 10 0.0007
709 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
710 OCULAR HYPERAEMIA 34 0.0007
711 SKIN FISSURES 14 0.0007
712 PELVIC PAIN 13 0.0007
713 HYPERGLYCAEMIA 26 0.0007
714 HEPATOMEGALY 7 0.0007
715 COLITIS 27 0.0007
716 FISTULA 8 0.0007
717 HYPOXIA 25 0.0007
718 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
719 HEART RATE INCREASED 70 0.0007
720 FEAR 19 0.0007
721 HYPOPHAGIA 18 0.0007
722 RETCHING 15 0.0007
723 HYPOTONIA 7 0.0007
724 EYE SWELLING 26 0.0007
725 POOR QUALITY SLEEP 15 0.0007
726 HYPOTHERMIA 7 0.0007
727 URINARY TRACT INFECTION 117 0.0007
728 CHOLECYSTITIS 8 0.0007
729 METASTASES TO BONE 11 0.0007
730 HEART RATE IRREGULAR 15 0.0007
731 OSTEOMYELITIS 12 0.0007
732 APHASIA 20 0.0007
733 DRUG TOXICITY 9 0.0007
734 ANAPHYLACTIC SHOCK 17 0.0007
735 BLOOD UREA INCREASED 11 0.0007
736 INJECTION SITE PRURITUS 44 0.0007
737 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
738 DIPLOPIA 17 0.0007
739 MUSCLE TWITCHING 15 0.0007
740 ABNORMAL WEIGHT GAIN 8 0.0006
741 DELUSION 10 0.0006
742 INTENTIONAL SELF-INJURY 13 0.0006
743 SCAR 11 0.0006
744 THERAPY PARTIAL RESPONDER 10 0.0006
745 SKIN REACTION 9 0.0006
746 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
747 HEPATOCELLULAR INJURY 9 0.0006
748 RIB FRACTURE 13 0.0006
749 BONE PAIN 37 0.0006
750 PROTEINURIA 12 0.0006
751 BRONCHOSPASM 9 0.0006
752 URINARY RETENTION 21 0.0006
753 RESTLESSNESS 23 0.0006
754 EOSINOPHILIA 11 0.0006
755 INFLUENZA 70 0.0006
756 MOVEMENT DISORDER 20 0.0006
757 BREAST CANCER 58 0.0006
758 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
759 THROMBOSIS 50 0.0006
760 INFUSION SITE PAIN 8 0.0006
761 LOCALISED INFECTION 15 0.0006
762 HAEMATOCHEZIA 34 0.0006
763 DYSPHONIA 36 0.0006
764 HAEMORRHOIDS 12 0.0006
765 MYOCARDIAL ISCHAEMIA 7 0.0006
766 DERMATITIS CONTACT 7 0.0006
767 SKIN DISCOLOURATION 28 0.0006
768 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
769 DEPRESSED MOOD 32 0.0006
770 DRUG INTERACTION 95 0.0006
771 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
772 RENAL IMPAIRMENT 50 0.0006
773 ECONOMIC PROBLEM 9 0.0006
774 PRODUCT ADMINISTRATION ERROR 12 0.0006
775 BLOOD BILIRUBIN INCREASED 16 0.0006
776 SPEECH DISORDER 31 0.0006
777 HEPATIC STEATOSIS 11 0.0006
778 PANCYTOPENIA 33 0.0006
779 ATAXIA 7 0.0006
780 SYNCOPE 59 0.0006
781 NEUROPATHY PERIPHERAL 56 0.0006
782 FEBRILE NEUTROPENIA 39 0.0006
783 BURNING SENSATION 41 0.0006
784 WRIST FRACTURE 7 0.0006
785 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
786 SNEEZING 13 0.0006
787 CHEST DISCOMFORT 59 0.0006
788 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
789 DYSGEUSIA 42 0.0006
790 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
791 DYSPHAGIA 53 0.0006
792 DYSARTHRIA 21 0.0006
793 GOUT 10 0.0006
794 HERPES ZOSTER 32 0.0006
795 DISTURBANCE IN ATTENTION 30 0.0006
796 EYE IRRITATION 32 0.0006
797 BRAIN OEDEMA 7 0.0006
798 LEUKOCYTOSIS 10 0.0006
799 MUSCLE ATROPHY 7 0.0006
800 PALLOR 15 0.0006
801 PRODUCT DISPENSING ERROR 12 0.0006
802 DRUG EFFECT INCOMPLETE 20 0.0006
803 CONSTIPATION 120 0.0005
804 ANAEMIA 104 0.0005
805 INCORRECT DOSE ADMINISTERED 124 0.0005
806 ACUTE MYOCARDIAL INFARCTION 16 0.0005
807 DRUG DEPENDENCE 87 0.0005
808 HAEMOPTYSIS 15 0.0005
809 RENAL DISORDER 25 0.0005
810 PULMONARY OEDEMA 24 0.0005
811 PRESYNCOPE 13 0.0005
812 FACE OEDEMA 9 0.0005
813 MOOD SWINGS 17 0.0005
814 HEMIPARESIS 9 0.0005
815 HEPATIC FAILURE 16 0.0005
816 BLOOD PRESSURE DECREASED 35 0.0005
817 HAEMORRHAGE 55 0.0005
818 LACTIC ACIDOSIS 17 0.0005
819 DEHYDRATION 70 0.0005
820 EYE HAEMORRHAGE 7 0.0005
821 NEOPLASM MALIGNANT 35 0.0005
822 SUICIDAL IDEATION 48 0.0005
823 ILLNESS 54 0.0005
824 INSURANCE ISSUE 8 0.0005
825 SHOCK 12 0.0005
826 MULTI-ORGAN FAILURE 9 0.0005
827 SEROTONIN SYNDROME 10 0.0005
828 PERICARDIAL EFFUSION 12 0.0005
829 UNEVALUABLE EVENT 39 0.0005
830 LUNG INFECTION 8 0.0005
831 EJECTION FRACTION DECREASED 8 0.0005
832 METASTASES TO LIVER 9 0.0005
833 CHILLS 60 0.0005
834 BALANCE DISORDER 44 0.0005
835 TREMOR 84 0.0005
836 LETHARGY 29 0.0005
837 PRODUCT PRESCRIBING ERROR 12 0.0005
838 PRODUCT SUBSTITUTION ISSUE 29 0.0005
839 BLINDNESS UNILATERAL 7 0.0005
840 PULMONARY EMBOLISM 47 0.0005
841 PANIC ATTACK 18 0.0005
842 FLUSHING 50 0.0005
843 PALPITATIONS 57 0.0005
844 BLOOD CREATINE PHOSPHOKINASE INCREASED 14 0.0005
845 OSTEONECROSIS OF JAW 12 0.0005
846 HYPERTHYROIDISM 7 0.0005
847 THINKING ABNORMAL 9 0.0005
848 HYPOKINESIA 7 0.0005
849 GASTROENTERITIS 7 0.0005
850 POLLAKIURIA 20 0.0005
851 LIMB INJURY 13 0.0005
852 ABDOMINAL PAIN LOWER 12 0.0005
853 ABNORMAL DREAMS 13 0.0005
854 INJECTION SITE SWELLING 36 0.0005
855 POST PROCEDURAL COMPLICATION 9 0.0005
856 BLOOD POTASSIUM DECREASED 14 0.0005
857 RHINORRHOEA 30 0.0005
858 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
859 HYPONATRAEMIA 26 0.0005
860 ORTHOSTATIC HYPOTENSION 8 0.0005
861 IRRITABILITY 27 0.0004
862 ENCEPHALOPATHY 11 0.0004
863 BRAIN FOG 7 0.0004
864 PRODUCT PHYSICAL ISSUE 9 0.0004
865 EPISTAXIS 33 0.0004
866 HALLUCINATION, AUDITORY 7 0.0004
867 HYPOGLYCAEMIA 21 0.0004
868 MUSCLE TIGHTNESS 7 0.0004
869 MENTAL STATUS CHANGES 12 0.0004
870 PULMONARY HYPERTENSION 9 0.0004
871 PRODUCT DOSE OMISSION ISSUE 127 0.0004
872 LACRIMATION INCREASED 13 0.0004
873 ABNORMAL BEHAVIOUR 17 0.0004
874 COGNITIVE DISORDER 20 0.0004
875 VERTIGO 26 0.0004
876 PHOTOSENSITIVITY REACTION 7 0.0004
877 BLOOD URINE PRESENT 8 0.0004
878 CEREBRAL HAEMORRHAGE 15 0.0004
879 CRYING 15 0.0004
880 RESPIRATORY FAILURE 30 0.0004
881 CIRCULATORY COLLAPSE 7 0.0004
882 HEAD INJURY 13 0.0004
883 MENORRHAGIA 8 0.0004
884 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
885 WITHDRAWAL SYNDROME 17 0.0004
886 NIGHTMARE 14 0.0004
887 MOOD ALTERED 11 0.0004
888 INJECTION SITE ERYTHEMA 50 0.0004
889 CATARACT 24 0.0004
890 HEPATIC FUNCTION ABNORMAL 15 0.0004
891 RASH MACULAR 14 0.0004
892 DISEASE RECURRENCE 19 0.0004
893 PRODUCT AVAILABILITY ISSUE 9 0.0004
894 DYSKINESIA 16 0.0004
895 ERECTILE DYSFUNCTION 10 0.0004
896 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
897 FLATULENCE 22 0.0004
898 UNRESPONSIVE TO STIMULI 10 0.0004
899 RASH GENERALISED 10 0.0004
900 ANGER 13 0.0004
901 DYSURIA 14 0.0004
902 HALLUCINATION, VISUAL 8 0.0004
903 DEATH 326 0.0004
904 AGRANULOCYTOSIS 7 0.0004
905 VAGINAL HAEMORRHAGE 16 0.0004
906 PREMATURE BABY 11 0.0004
907 CHOLESTASIS 7 0.0004
908 INFLUENZA LIKE ILLNESS 30 0.0004
909 STAPHYLOCOCCAL INFECTION 12 0.0004
910 NERVOUSNESS 19 0.0004
911 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
912 VISUAL ACUITY REDUCED 12 0.0004
913 VIRAL INFECTION 12 0.0004
914 RHABDOMYOLYSIS 15 0.0004
915 FEELING COLD 10 0.0004
916 SEPSIS 40 0.0004
917 ORAL HERPES 7 0.0004
918 ORAL PAIN 8 0.0004
919 EYE PRURITUS 12 0.0004
920 EMOTIONAL DISORDER 11 0.0004
921 EMOTIONAL DISTRESS 43 0.0004
922 DRUG EFFECT DECREASED 19 0.0004
923 UPPER LIMB FRACTURE 7 0.0004
924 INTENTIONAL DOSE OMISSION 10 0.0004
925 HYPERSOMNIA 10 0.0003
926 HAEMATOMA 9 0.0003
927 SEIZURE 40 0.0003
928 CEREBROVASCULAR ACCIDENT 58 0.0003
929 INJECTION SITE WARMTH 7 0.0003
930 BRADYCARDIA 18 0.0003
931 PSYCHOTIC DISORDER 10 0.0003
932 PAIN OF SKIN 9 0.0003
933 MYELOSUPPRESSION 12 0.0003
934 DIABETIC KETOACIDOSIS 8 0.0003
935 CONVULSION 19 0.0003
936 COVID-19 58 0.0003
937 PNEUMONITIS 9 0.0003
938 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
939 DEMENTIA 9 0.0003
940 MENTAL DISORDER 14 0.0003
941 AGEUSIA 8 0.0003
942 NERVOUS SYSTEM DISORDER 10 0.0003
943 SKIN EXFOLIATION 27 0.0003
944 CARDIAC ARREST 26 0.0003
945 ACUTE RESPIRATORY FAILURE 6 0.0003
946 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
947 ASCITES 9 0.0003
948 URINARY INCONTINENCE 9 0.0003
949 CARDIAC FAILURE CONGESTIVE 24 0.0003
950 DRUG ADMINISTRATION ERROR 9 0.0003
951 RESPIRATORY DISTRESS 8 0.0003
952 INJECTION SITE HAEMORRHAGE 23 0.0003
953 NEOPLASM PROGRESSION 10 0.0003
954 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
955 PLATELET COUNT DECREASED 29 0.0003
956 NEUTROPHIL COUNT DECREASED 11 0.0003
957 DRY SKIN 36 0.0003
958 DRUG EXPOSURE DURING PREGNANCY 9 0.0003
959 INJECTION SITE PAIN 81 0.0003
960 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 53 0.0003
961 INJECTION SITE RASH 8 0.0003
962 SKIN BURNING SENSATION 18 0.0003
963 ABASIA 6 0.0002
964 ARRHYTHMIA 11 0.0002
965 MULTIPLE SCLEROSIS 11 0.0002
966 INJECTION SITE BRUISING 18 0.0002
967 BLINDNESS 9 0.0002
968 THERAPY CESSATION 11 0.0002
969 HYPOACUSIS 9 0.0002
970 NEUTROPENIA 28 0.0002
971 MALIGNANT NEOPLASM PROGRESSION 21 0.0002
972 BLOOD GLUCOSE INCREASED 38 0.0002
973 CARDIAC FAILURE 16 0.0002
974 PRODUCT ADHESION ISSUE 7 0.0002
975 DEPENDENCE 10 0.0002
976 PLASMA CELL MYELOMA 7 0.0002
977 DISEASE PROGRESSION 21 0.0002
978 ABORTION SPONTANEOUS 7 0.0002
979 EXTRA DOSE ADMINISTERED 7 0.0002
980 ACNE 13 0.0002
981 PRODUCT DOSE OMISSION 11 0.0002
982 BLOOD GLUCOSE DECREASED 8 0.0002
983 DRUG DOSE OMISSION 26 0.0002
984 PROSTATE CANCER 12 0.0001
985 DRUG WITHDRAWAL SYNDROME 13 0.0001
986 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
987 AGGRESSION 7 0.0001
988 CARDIAC DISORDER 13 0.0001
989 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
990 ECZEMA 7 0.0001
991 THERAPY INTERRUPTED 9 0.0001
992 DEVICE ISSUE 9 0.0001